Article
Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease.
The American journal of the medical sciences - 1 Mar 2013
Zhong Yuan, Zheng Xueli, Miao Ya, Wan Lili, Yan Hong, Wang Beiyun
Abstract excerpt
BACKGROUND: The aim of this study was to evaluate the effect of CYP2D6*10 and APOE polymorphisms on both steady-state plasma concentrations (Cp) and clinical response of donepezil in patients with mild-to-moderate Alzheimer's disease (AD). METHODS: A total of 110 Chinese AD patients participated in this study. Patients were treated with 5 to 10 mg of donepezil daily for 6 months. The genotypes of CYP2D6*10 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
